DAFTAR PUSTAKA
Al-Gethamy, M.M., Faidah, H.S., Adetunji, H.A., Haseeb, A., Ashgar, S.S., Mohanned, T.K., dkk., 2017. Risk factors associated with multi-drug- resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia - a matched case–control study. Journal of International Medical Research, 45: 1181–1189.
Almaghrabi, M.K., Joseph, M.R.P., Assiry, M.M., dan Hamid, M.E., 2018.
Multidrug-Resistant Acinetobacter baumannii : An Emerging Health Threat in Aseer Region, Kingdom of Saudi Arabia. Canadian Journal of Infectious Diseases and Medical Microbiology, 2018: 1–4.
Almasaudi, S.B., 2018. Acinetobacter spp. as nosocomial pathogens:
Epidemiology and resistance features. Saudi Journal of Biological Sciences, 25: 586–596.
Banerjee, T., Mishra, A., Das, A., Sharma, S., Barman, H., dan Yadav, G., 2018.
High Prevalence and Endemicity of Multidrug Resistant Acinetobacter spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India.
Journal of Pathogens, 2018: 1–8.
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M.P., dkk., 2007. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. Journal of Antimicrobial Chemotherapy, 61: 417–420.
Bauer, L.A., 2008. Applied Clinical Pharmacokinetics, 2nd ed. The McGraw-Hill Medicine.
Bbosa, G.S., Mwebaza, N., Odda, J., Kyegombe, D.B., dan Ntale, M., 2014.
Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance. Health, 06: 410–425.
CDC, 2013. Antibiotic Resistance Threats. Department of Health And Services, Center of Disease Control and Prevention.
https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Diakses 13 Desember 2018
Chang, C.-J., Chang, B.-L., Tsai, K.-C., Lai, Y.-J., dan Fan, C.-M., 2012.
Acinetobacter baumannii Post-Operative Meningitis. Surgical Infections, 13: 338–339.
Chang, H.-C., Chen, Y.-C., Lin, M.-C., Liu, S.-F., Chung, Y.-H., Su, M.-C., dkk., 2011. Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia. Journal of the Formosan Medical Association, 110: 564–571.
Chung, D.R., Song, J.-H., Kim, S.H., Thamlikitkul, V., Huang, S.-G., Wang, H., dkk., 2011. High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia. American Journal of Respiratory and Critical Care Medicine, 184: 1409–1417.
Collin, P.H., 2005. Dictionary of Medical Terms. A & C Black, London.
Daniels, T.L., Deppen, S., Arbogast, P.G., Griffin, M.R., Schaffner, W., dan Talbot, T.R., 2008. Mortality Rates Associated With Multidrug-Resistant Acinetobacter baumannii Infection in Surgical Intensive Care Units.
Infection Control & Hospital Epidemiology, 29: 1080–1083.
Dewi, F.N.K., 2017. 'Evaluasi Kesesuaian Penggunaan Antibiotik Empiris dan Definitif pada Pasien HCAP Rawat Inap di RSUP Dr. Sardjito Yogyakarta', . Universitas Gadjah Mada, Yogyakarta.
Estiningsih, D., 2015. 'Identifikasi Infeksi Multidrug Resistant Organisms (MDRO) Pada Pasien Yang Dirawat Di Bangsal Neonatal Intensive Care Unit (NICU) RSUP Dr. Soeradji Tirtonegoro Klaten',Tesis. Universitas Gadjah Mada, Yogyakarta.
Fishbain, J. dan Peleg, A.Y., 2010. Treatment of Acinetobacter Infections.
Clinical Infectious Diseases, 51: 79–84.
Gordon, N.C. dan Wareham, D.W., 2010. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. International Journal of Antimicrobial Agents, 35: 219–226.
Hakim,L., 2012. Farmakokinetika Klinik, Farmasi Klinis. Bursa Ilmu, Yogyakarta.
Howard, A., O’Donoghue, M., Feeney, A., dan Sleator, R.D., 2012. Acinetobacter baumannii: An emerging opportunistic pathogen. Virulence, 3: 243–250.
Jang, T.-N., Lee, S.-H., Huang, C.-H., Lee, C.-L., dan Chen, W.-Y., 2009. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case–control study. Journal of Hospital Infection, 73: 143–150.
Jefry, 2018. 'Pola Kepekaan Isolat Klinik A. Baumannii di RSUP Soeradji Tirtonegoro Terhadap berbagai macam Antibiotik', , Laporan Penelitian (Skripsi), . Universitas Gadjah Mada.
Kassamali, Z., Jain, R., dan Danziger, L.H., 2015. An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics.
International Journal of Infectious Diseases, 30: 125–132.
Khan, H.A., Baig, F.K., dan Mehboob, R., 2017. Nosocomial infections:
Epidemiology, prevention, control and surveillance. Asian Pacific Journal of Tropical Biomedicine, 7: 478–482.
Leekha, S., Terrell, C.L., dan Edson, R.S., 2011. General Principles of Antimicrobial Therapy. Mayo Clinic Proceedings, 86: 156–167.
Lin, P.-C., Chang, C.-H., Hsu, P.-I., Tseng, P.-L., dan Huang, Y.-B., 2010. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis: Critical Care Medicine, 38: 1197–1205.
M100-S24: Performance Standards for Antimicrobial Susceptibility Testing;
Twenty-Fourth Informational Supplement, 2019, Clinical and Laboratory Standart Institute ,230.
M100-S24: Performance Standards for Antimicrobial Susceptibility Testing;
Twenty-Fourth Informational Supplement, 2014, Clinical and Laboratory Standart Institute ,230.
Manchanda, V., Sachaita, S., dan Singh, N.P., 2010. Multidrug Resistant Acinetobacter. Journal of Global Infectius Disease, 2(3): 291–304.
Manik, M.P.L., 2018. 'Analisis Pola Resistensi dan Evaluasi Penggunaan Antibiotik Empiris Serta Analisis Biaya pada Pasien Pneumonia Nosokomial di Ruang ICU RSUP Dr. Sardjito Yogyakarta', . Universitas Gadjah Mada, Yogyakarta.
Maragakis, L.L. dan Perl, T.M., 2008. Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options. Clinical Infectious Diseases, 46: 1254–1263.
Mehraj, M., 2018. A review of Wagner classification and current concepts in management of diabetic foot, International Journal of Orthopaedics Sciences, 4(1): 933-935.
Mehrotra, R., De Gaudio, R., dan Palazzo, M., 2004. Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness. Intensive Care Medicine, 30: 2145–2156.
Menkes RI, 2011a. Peraturan Menteri Kesehatan Republik Indonesia Nomor 2406/MENKES/PER/XII/2011 Tentang Pedoman Umum Penggunaan Antibiotik.
Menkes RI, 2011b. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik.
Menkes RI, 2015. Permenkes Ri Nomor 8 Tahun 2015 Tentang Program Pengendalian Resistensi Antimikroba Di Rumah Sakit.
Muley, V., Bhore, A., Shete, V., dan Ghadage, D., 2010. Multi-drug resistant Acinetobacter ventilator-associated pneumonia. Lung India, 27: 217.
Murphy, J.E. dan American Society of Health-System Pharmacists (Editor), 2016.
Clinical Pharmacokinetics, 6th edition. ed. American Society of Health- System Pharmacists, Bethesda, MD.
Nirwati, H. dan Nuryastuti, T., 2018. Pola Kepekaan Isolat Klinik A. Baumannii Di RSUP Dr. Soeradji Tirtonegoro Terhadap Berbagai Macam Antibiotik.
Pratiwi, S, 2008. Mikrobiologi Farmasi, 1st ed. Erlangga, Jakarta.
Rahmantika, F., 2016. 'Identifikasi Infeksi Multi Drug Resistant Organism pada pasien yang dirawat di bangsal Pediatric Intersive Care Unit (PICU) RSUP Dr. Soeradji Tirtonegoro Klaten Periode Januari 2013-Desember 2015', Tesis . Universitas Gadjah Mada, Yogyakarta.
Shields, R.K., Kwak, E.J., Potoski, B.A., Doi, Y., Adams-Haduch, J.M., Silviera, F.P., dkk., 2011. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagnostic Microbiology and Infectious Disease, 70: 246–252.
Siwakoti, S., Subedi, A., Sharma, A., Baral, R., Bhattarai, N.R., dan Khanal, B., 2018. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study. Antimicrobial Resistance & Infection Control, 7: .
Tängdén, T., 2014. Combination antibiotic therapy for multidrug-resistant Gram- negative bacteria. Upsala Journal of Medical Sciences, 119: 149–153.
van Lunzen, J. dan Altfeld, M., 2014. Sex Differences in Infectious Diseases- Common but Neglected. Journal of Infectious Diseases, 209: S79–S80.
